Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.

Translated title of the contribution: Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.

R.S. Kahn, S.C. Schulz, V.D. Palazov, E.B. Reyes, M. Brecher, O. Svensson, H.M. Andersson, D. Meulien

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEfficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
Original languageUndefined/Unknown
Pages (from-to)832-842
Number of pages11
JournalJournal of Clinical Psychiatry
Volume68
Issue number6
Publication statusPublished - 2007

Cite this